论文部分内容阅读
目的观察雾化吸入可必特在缓解支气管哮喘急性发作期的疗效。方法随机抽取支气管哮喘急性发作期患者68例,分为对照组34例,治疗组34例。治疗组在常规治疗的基础上给予可必特2.5 ml雾化吸入2次/d。治疗前后症状、体征、疗效及肺功能等参数进行比较。结果治疗组显效率为58.8%,有效率为26.5%,总有效率为85.3%;对照组显效率为8.8%,有效率为17.6%,,总有效率为26.5%,两组疗效比较,差异有统计学意义(P<0.05);另外治疗组在肺功能的改善方面与对照组比较差异有统计学意义(P<0.05)。结论可必特雾化吸入缓解支气管哮喘急性发作疗效确切,方法简便。
Objective To observe the inhalation of atomization may be special in the treatment of acute exacerbation of bronchial asthma. Methods A total of 68 patients with acute exacerbation of bronchial asthma were randomly divided into control group (34 cases) and treatment group (34 cases). On the basis of routine treatment, the treatment group was given bleb 2.5 ml aerosol inhalation 2 times / d. Before and after treatment, symptoms, signs, efficacy and pulmonary function parameters were compared. Results The effective rate was 58.8% in the treatment group, the effective rate was 26.5%, the total effective rate was 85.3%; in the control group, the effective rate was 8.8%, the effective rate was 17.6%, the total effective rate was 26.5% (P <0.05). In addition, the difference between the two groups was statistically significant (P <0.05) in lung function improvement compared with the control group. Conclusions Kebite nebulization can ameliorate acute exacerbation of bronchial asthma with exact and simple method.